PTPI
Petros Pharmaceuticals
PTPI
PTPI
Delisted
PTPI was delisted on the 21st of May, 2025.
16 hedge funds and large institutions have $1.3M invested in Petros Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
64% less capital invested
Capital invested by funds: $3.58M → $1.3M (-$2.28M)
Holders
16
Holding in Top 10
–
Calls
$112K
Puts
$126K
Top Buyers
| 1 | +$269K | |
| 2 | +$162K | |
| 3 | +$107K | |
| 4 |
Two Sigma Advisers
New York
|
+$96.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.5K |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$225K | |
| 3 | -$177K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$176K |
| 5 |
Squarepoint
New York
|
-$119K |